Building Evidence During Crisis: Breast Cancer Care Pathways in a Resource-Constrained Setting

Building Evidence During Crisis: Breast Cancer Care Pathways in a Resource-Constrained Setting
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

          Conducting this study required a true multidisciplinary task force involving attending physicians, breast surgery residents, and collaborators from different medical specialties, both during and after the pandemic period. Data collection itself became a major challenge, as clinical workflows were constantly changing and healthcare professionals were simultaneously balancing patient care, surgical backlogs, academic responsibilities, and the emotional burden imposed by the pandemic.

          One of the strongest motivations behind this project was the belief that experiences from resource-constrained public healthcare systems also deserve scientific visibility and international discussion. Despite the limitations inherent to retrospective analyses performed in middle-income settings, we believed that documenting the experience of a large public oncology center during the pandemic could provide valuable external perspectives on how cancer care pathways behave under healthcare system stress.

           In many ways, this study was also an exercise in resilience — not only in maintaining cancer care during a global crisis, but also in sustaining academic collaboration, clinical research, and scientific production in a setting with limited resources and continuously shifting priorities.

“This experience reinforced our conviction that meaningful clinical research can emerge even under adverse conditions when collaborative academic networks remain active.”

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Breast Cancer
Life Sciences > Biological Sciences > Cancer Biology > Cancers > Breast Cancer
Surgical Oncology
Life Sciences > Biological Sciences > Cancer Biology > Cancer Therapy > Surgical Oncology
Public Health
Life Sciences > Health Sciences > Public Health
Oncology
Life Sciences > Health Sciences > Clinical Medicine > Oncology
COVID19
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Infectious Diseases > COVID19
  • BMC Cancer BMC Cancer

    This is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers.

Related Collections

With Collections, you can get published faster and increase your visibility.

Neoadjuvant and adjuvant therapy for gynecologic malignancies

Neoadjuvant and adjuvant therapies play crucial roles in the management of gynecologic malignancies, including ovarian, cervical, and endometrial cancers. These treatment strategies aim to improve surgical outcomes by either reducing tumor size before surgery (neoadjuvant) or eliminating residual disease postoperatively (adjuvant). Recent advancements in understanding tumor biology, patient selection, and the integration of novel therapies have reshaped the landscape of gynecologic oncology, making it essential to explore the various modalities, including chemotherapy and radiation therapy, that can enhance treatment efficacy and patient survival.

The ongoing research in this field is vital, as it contributes to improving treatment protocols and patient quality of life. Recent breakthroughs have highlighted the significance of personalized treatment approaches, such as targeted therapies and immunotherapies, which have shown promising results in clinical trials. By exploring the optimal sequencing of neoadjuvant and adjuvant therapies, researchers can provide insights into downstaging tumors, minimizing toxicity, and maximizing the overall effectiveness of treatments, leading to better patient outcomes.

Continued exploration and innovation in neoadjuvant and adjuvant therapies hold the potential to transform the management of gynecologic malignancies. Future research may focus on refining treatment regimens, identifying biomarkers for response, and integrating multidisciplinary approaches to optimize surgical and therapeutic outcomes. As we deepen our understanding of tumor heterogeneity and resistance mechanisms, new therapeutic strategies may emerge, offering hope for improved prognosis in patients with these challenging cancers.

  • Efficacy of neoadjuvant and adjuvant chemotherapy
  • Role of radiation therapy in treatment protocols
  • Impact of neoadjuvant vs. adjuvant approaches on fertility and quality of life
  • Strategies for downstaging tumors
  • Integration of novel therapies in surgical planning
  • Resistance mechanisms and strategies for overcoming them
  • Role of molecular profiling in guiding therapy
  • Clinical trials landscape and future directions

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Jul 21, 2026

Prehabilitation in cancer

Prehabilitation in cancer care is an emerging field focused on optimizing patients' physical and psychological well-being prior to undergoing surgery or treatment. By incorporating strategies such as exercise, nutritional support, and psychological interventions, prehabilitation aims to enhance patients’ resilience and overall health outcomes. The concept has gained traction as healthcare professionals recognize the significance of preparing patients for the demands of cancer treatment and recovery, ultimately aiming to improve surgical outcomes and quality of life.

The importance of integrating prehabilitation into cancer care has been underscored by recent advances in research demonstrating its potential benefits. Studies have shown that tailored exercise programs and nutritional interventions can significantly improve treatment outcomes, reduce complications, and enhance recovery times. As healthcare systems increasingly prioritize patient-centered approaches, the implementation of prehabilitation practices may lead to more effective cancer management and improve the overall experience for patients navigating their cancer journey.

Continued research in this area has the potential to revolutionize cancer care practices, paving the way for the development of standardized prehabilitation protocols tailored to individual patient needs. This research may also inspire innovations in telehealth and digital health solutions that facilitate remote prehabilitation interventions, making these essential services more accessible to patients regardless of their geographical location.

Topics welcome to this Collection include, but are not limited to, the following:

  • Impact of prehabilitation on surgical outcomes
  • Exercise interventions in cancer care
  • Nutritional support during prehabilitation
  • Prehabilitation and chemotherapy outcomes

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Jan 20, 2027